Category
Tofacitinib
CAS Number
477600-75-2
Molecular Formula
C16H20N6O
Molecular Weight
312.4 g/mol
Synonym

 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile ;  Tasocitinib; (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile;

Keywords
Enzyme inhibitors
Heterocycles
Nucleotides
bases and related reagents
Pharmaceutical Standards
Intermediates
Fine Chemicals
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Tofacitinib is an oral Janus kinase (JAK) inhibitor used to treat autoimmune and inflammatory diseases by reducing immune system overactivity. It is commonly prescribed for conditions such as rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and certain skin disorders.